The technology used in vision correction surgery is genuinely important — but it is consistently misrepresented in patient-facing marketing. Practices advertise laser brand names as though brand alone determines outcomes. Patients research platform names without understanding what the differences actually are or whether those differences apply to their specific case.
This guide cuts through the marketing language and provides an honest, clear explanation of what the relevant technology choices in LASIK, PRK, and EVO ICL actually mean for your outcome. Understanding this material makes you a better-informed patient and helps you ask better questions as part of the process of choosing an eye surgeon.
The Two Laser Types in LASIK: Excimer and Femtosecond
LASIK involves two distinct laser systems operating on different tissues in a specific sequence. Understanding the role of each is foundational.
The femtosecond laser is used first. Its function is to create the corneal flap — the thin hinged layer of corneal tissue that is lifted before treatment and repositioned afterward. Before femtosecond lasers became available, this step was performed with a mechanical microkeratome blade. Femtosecond flap creation is more precise and produces more consistent flap thickness than blade-based methods. The major femtosecond laser platforms used for LASIK flap creation include the Ziemer LDV, the Alcon IntraLase, the Johnson & Johnson Visumax (used in SMILE procedures as well), and the Bausch + Lomb Technolas. These platforms have meaningful but relatively modest differences in flap characteristics.
The excimer laser performs the actual vision correction. After the flap is lifted, the excimer laser ablates a precisely calculated amount of corneal tissue to reshape the cornea’s curvature, thereby correcting the refractive error. The excimer laser platforms differ in their speed, beam profile, eye tracking capability, and the sophistication of their ablation algorithms.
The major excimer laser platforms in current use include:
- Alcon WaveLight EX500: One of the fastest excimer laser platforms in clinical use, capable of 1050 Hz repetition rate. Speed reduces treatment time, which reduces the risk of corneal dehydration affecting the ablation profile during the procedure. The WaveLight is associated with a large published outcomes dataset.
- Johnson & Johnson iDesign/STAR S4 IR: The iDesign system uses advanced wavefront sensing to capture a high-resolution aberration map of the eye and incorporates that data into a personalized treatment plan. FDA approval data for iDesign showed a significant proportion of patients achieving supranormal vision outcomes.
- Technolas/Bausch + Lomb Teneo: Offers both wavefront-optimized and topography-guided treatment options and is used internationally with a substantial evidence base.
- Schwind Amaris: Widely used in Europe and internationally, with a strong published evidence base in European refractive surgery centers.
Treatment Planning: Wavefront-Guided, Wavefront-Optimized, and Topography-Guided
Beyond the hardware platform, the treatment planning algorithm is often the more important variable affecting visual quality outcomes. The three main approaches are:
Wavefront-optimized treatment applies the standard prescription correction while compensating for edge effects that would otherwise introduce spherical aberration. This is considered standard treatment for most uncomplicated prescriptions and produces excellent outcomes for the majority of patients.
Wavefront-guided treatment uses a detailed aberrometry map of the eye’s optical system — capturing higher-order aberrations in addition to the standard refractive prescription — to create a personalized treatment plan. The treatment is customized not just to the prescription but to the unique optical signature of the individual eye. Published clinical trial data for wavefront-guided LASIK shows that a meaningful percentage of patients achieve better vision after surgery than they had with their best spectacle correction beforehand. This is called “supranormal” vision, and it is achievable because glasses cannot correct higher-order aberrations, while wavefront-guided laser treatment can reduce them.
Topography-guided treatment uses data from the corneal topography map — the surface shape of the cornea — rather than the wavefront aberrometer to personalize the ablation pattern. Topography-guided treatment has particular advantages for patients with irregular corneas, including those with forme fruste keratoconus (a mild, subclinical form of corneal ectasia), prior corneal surgery, or significant corneal irregularity that generates visual symptoms with standard treatment.
The FDA’s approval data for the Alcon Contoura Vision topography-guided system showed remarkable outcomes, with a substantial majority of patients achieving 20/20 or better and many achieving 20/15. This level of outcome data drove rapid adoption of topography-guided treatment in the United States after FDA approval.
For most patients without significant corneal irregularity, the outcome differences between wavefront-guided and topography-guided treatment are modest. For patients with irregular corneas, topography-guided treatment may be the superior option.
The SMILE Procedure: A Different Laser Approach
SMILE (Small Incision Lenticule Extraction) is a procedure performed entirely with a femtosecond laser, without an excimer laser and without creating a LASIK flap. The femtosecond laser creates a small lens-shaped piece of corneal tissue (a lenticule) inside the cornea, which is then extracted through a small incision. The result is correction of myopia and astigmatism without a flap.
SMILE is performed using the Zeiss VisuMax platform. Its advantages include: no flap-related complications, less impact on corneal biomechanical strength than LASIK (because more stromal tissue is preserved intact), and lower rates of post-surgical dry eye compared to LASIK in some studies. Its limitations include: longer visual recovery than LASIK in many patients, less flexibility in the range of corrections that can be addressed, and a more limited body of long-term outcome data compared to LASIK.
Not all practices that offer LASIK also offer SMILE, and the learning curve for SMILE is distinct from that for LASIK. When considering SMILE, ask specifically about the surgeon’s SMILE case volume, distinct from their overall refractive surgery experience.
PRK: No Flap, No Femtosecond Laser Required
PRK (Photorefractive Keratectomy) uses the excimer laser to ablate the corneal surface directly, without creating a flap. The same excimer laser platforms used for LASIK are used for PRK — the distinction is in the pre-treatment preparation (removal of the corneal epithelium by chemical, brush, or blunt instrument rather than femtosecond laser flap creation).
PRK is the preferred procedure for patients who cannot have LASIK — typically because their corneas are too thin for a safe LASIK procedure, or because their occupational or lifestyle exposure to eye trauma makes a flap inadvisable. The visual outcomes of PRK are equivalent to LASIK at six months and beyond. The recovery trajectory is different: PRK patients typically experience more discomfort in the first week and reach stable vision more slowly (weeks to months rather than days).
The excimer laser platform used for PRK matters for the same reasons it matters in LASIK. The choice between wavefront-optimized, wavefront-guided, and topography-guided treatment applies equally to PRK. See our PRK Surgery Awards resources for information on how PRK technology assessment applies to surgeon evaluation.
EVO ICL Technology: Less About Lasers, More About Lens
EVO ICL (Implantable Collamer Lens) is a fundamentally different approach. Rather than reshaping the cornea with a laser, the surgeon implants a thin, flexible lens behind the iris and in front of the natural crystalline lens. No corneal tissue is removed.
The lens itself is manufactured by STAAR Surgical and made from Collamer, a biocompatible material containing collagen. The EVO design (the current generation) incorporates a central aqueous port that eliminates the need for the peripheral iridotomies required by earlier ICL models. The lens is available in a range of powers to correct myopia up to approximately -20 diopters — far beyond what is safely achievable with laser correction — and can correct significant degrees of astigmatism.
For EVO ICL, the technology evaluation is different than for LASIK:
- Lens sizing is a critical factor. The EVO ICL must be sized precisely to fit the patient’s internal anatomy. Improper sizing can lead to elevated intraocular pressure, lens rotation, or inadequate optical clearance. Surgeons who perform high volumes of EVO ICL develop considerable experience in sizing judgment.
- The surgical technique for lens implantation is distinct from laser refractive surgery and has its own learning curve.
- Diagnostic equipment used to measure the anterior chamber dimensions (used for ICL sizing) includes ultrasound biomicroscopy and anterior segment OCT. The quality and precision of these measurements matters.
See our EVO ICL Awards resources for information on EVO ICL-specific evaluation criteria.
Diagnostic Equipment: What Should Be in the Workup
The technology used before surgery — to evaluate your candidacy and plan your treatment — is as important as the surgical technology. Key diagnostic instruments:
Corneal topography. Maps the shape of the anterior corneal surface. Identifies irregular astigmatism, corneal ectasia (keratoconus), and anatomical features that influence treatment planning.
Wavefront aberrometer. Measures higher-order optical aberrations of the entire eye, not just the corneal surface. Used for wavefront-guided treatment planning and for patient counseling about expected visual quality outcomes.
Optical coherence tomography (OCT) of the cornea. Provides high-resolution cross-sectional images of the cornea, including precise corneal thickness measurements that are more accurate than ultrasound pachymetry.
Scheimpflug imaging (Pentacam). Provides three-dimensional maps of both the anterior and posterior corneal surfaces as well as corneal thickness throughout the entire cornea — critical for detecting early keratoconus and assessing suitability for LASIK.
Dry eye assessment. Tear film analysis (including tear break-up time, Schirmer’s test, and meibomian gland evaluation) is an important pre-operative screening step. Significant pre-existing dry eye is a relative contraindication for LASIK and should influence procedure selection.
A practice that performs all of these evaluations as part of its standard pre-operative workup is providing a level of diagnostic thoroughness that protects both the patient and the practice. A practice that abbreviates this workup to reduce consultation time is taking on risk.
The Right Question to Ask About Technology
Rather than asking which brand a practice uses — which opens the door to a marketing monologue — ask these specific questions:
1. Is my treatment wavefront-guided, wavefront-optimized, or topography-guided, and why is that the right choice for my specific eyes? 2. What excimer laser platform will you use, and how long has your practice been using it? 3. Has your practice’s outcome data on this platform been reviewed or published? 4. What pre-operative diagnostic equipment does your practice use, and will I have a Scheimpflug map and a wavefront aberrometry measurement as part of my workup?
These questions move the conversation from brand names to clinical substance — which is where the real evaluation belongs.
Related knowledge pages:
- Surgeon experience and why case volume matters
- Questions to ask during your eye surgery consultation
Answer pages: